Condition: Myasthenia Gravis · Sponsor: Vitaccess Ltd
Vitaccess Real MG (VRMG) is a patient registry designed to capture longitudinal observational data on myasthenia gravis (MG), its treatment, and impact on symptoms, daily activities, and quality of life (QoL). The duration of the registry is 10 years from launch, and approximately 600 patients will be recruited in the US and Europe with no defined upper limit. The registry will link relevant patient- and healthcare professional (HCP)-reported data with clinical data from medical records. Patients will be recruited at clinical sites in all participating countries. In the US only, patients can additionally be recruited via community neurologists or direct-to-patient recruitment.
This description comes directly from the study's public registry record.
Mark JW Larkin, PhD · +44 1865818983 · mark.larkin@vitaccess.com
Always discuss trial participation with your own doctor first.
| UCI Health | Orange, California, United States | Recruiting |
| HSHS St. Elizabeth's Hospital | O'Fallon, Illinois, United States | Recruiting |
| UK HealthCare - University of Kentucky | Lexington, Kentucky, United States | Recruiting |
| Neurology Associates of South Jersey | Lumberton, New Jersey, United States | Recruiting |
| Medical University South Carolina | Charleston, South Carolina, United States | Recruiting |
| University of Texas Health Science Center at Houston | Houston, Texas, United States | Recruiting |
| Vitaccess Ltd | London, London, United Kingdom | Recruiting |
| University Hospitals Birmingham | Birmingham, United Kingdom | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT06064461